Article Versions Notes

Franceschini D, Comito T, Di Gallo A, Vernier V, Marzo MA, Di Cristina L, Marini B, Lo Faro L, Stefanini S, Spoto R, et al. Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial. Current Oncology. 2022; 29(10):7858-7867. https://doi.org/10.3390/curroncol29100621

Franceschini, Davide, Tiziana Comito, Anna Di Gallo, Veronica Vernier, Marco A. Marzo, Luciana Di Cristina, Beatrice Marini, Lorenzo Lo Faro, Sara Stefanini, Ruggero Spoto, and et al. 2022. "Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial" Current Oncology 29, no. 10: 7858-7867. https://doi.org/10.3390/curroncol29100621

Franceschini, D., Comito, T., Di Gallo, A., Vernier, V., Marzo, M. A., Di Cristina, L., Marini, B., Lo Faro, L., Stefanini, S., Spoto, R., Dominici, L., Franzese, C., & Scorsetti, M. (2022). Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial. Current Oncology, 29(10), 7858-7867. https://doi.org/10.3390/curroncol29100621